Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Guangxiao Lin"'
Autor:
Shenglong Zhu, Ninghan Feng, Guangxiao Lin, Yuelin Tong, Xuan Jiang, Qin Yang, Shunhe Wang, Wei Chen, Zhao He, Yong Q Chen
Publikováno v:
Cellular Physiology and Biochemistry, Vol 48, Iss 6, Pp 2318-2336 (2018)
Background/Aims: Rapamycin (Rp), the main mammalian target of rapamycin complex inhibitor, is a promising therapeutic agent for breast cancer. However, metabolic disorders and drug resistance reduce its efficacy. Epidemiological, clinical, and experi
Externí odkaz:
https://doaj.org/article/ab20c03d0b6641b783eae550162ed0f7
Autor:
Guangxiao Lin, Shenglong Zhu, Yikuan Wu, Ci Song, Wanjing Wang, Yuan Zhang, Yue-Lei Chen, Zhao He
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
Abstract All-trans retinoic acid (ATRA), one of vitamin A derivatives, shows greater growth inhibition of breast cancer cell for ER-positive than ER-negative cells, while triple negative breast cancer cell such as MDA-MB-231 cell is poorly responsive
Externí odkaz:
https://doaj.org/article/25282b1404454385b0d5de2fe32b9f8f
Autor:
Yuelin Tong, Yong Q. Chen, Ninghan Feng, Qin Yang, Wei Chen, Guangxiao Lin, Shunhe Wang, Zhao He, Shenglong Zhu, Xuan Jiang
Publikováno v:
Cellular Physiology and Biochemistry, Vol 48, Iss 6, Pp 2318-2336 (2018)
Background/Aims: Rapamycin (Rp), the main mammalian target of rapamycin complex inhibitor, is a promising therapeutic agent for breast cancer. However, metabolic disorders and drug resistance reduce its efficacy. Epidemiological, clinical, and experi
Autor:
Shenglong Zhu, Jianping Gong, Xiaowei Jiang, Wei Chen, Yong Q. Chen, Siyuan Jiang, Guangxiao Lin, Zhao He
Publikováno v:
Cell Biology International. 42:180-186
Intake of ω-3 PUFAs reduces the frequency of breast cancer, and GPR120 receptor transduces ω-3 PUFAs signaling to increase insulin sensitivity in mice, but whether GPR120 mediates ω-3 PUFAs signaling to inhibit breast carcinogenesis is currently u
Autor:
Zhao He, Shenglong Zhu, Yong Q. Chen, Yikuan Wu, Guangxiao Lin, Wei Chen, Ci Song, Ninghan Feng
Publikováno v:
Oncotarget
Retinoic acid (RA), is a promising therapeutic agent for the treatment of breast cancer. However, metabolic disorders and drug resistance reduce the efficacy of RA. In this study, we found that RA and ω-3 polyunsaturated fatty acids (ω-3 PUFAs) syn
Publikováno v:
Cell Biology International. 41:890-897
Breast cancer is a leading type of cancer in women and generally classified into three subtypes of ER+ /PR+ , HER2+ and triple negative. Both omega-3 polyunsaturated fatty acids and vitamin D3 play positive role in the reduction of breast cancer inci
Autor:
Lengyun Wei, Xuan Jiang, Xuyang Lu, Jingwei Zhang, Yong Q. Chen, Qingwen He, Dou Dou Zhu, Shenglong Zhu, Yuelin Tong, Guangxiao Lin
Publikováno v:
Nutrition and cancer. 72(4)
Kudingcha is implicated in alleviating metabolic disorders in traditional Chinese medicine. However, the role of Kudingcha, one of the Ligustrum robustum species, in metabolic regulations and its antitumor activity in triple-negative breast cancer (T
Autor:
Lei Ma, Jianying Qi, Guiping Ren, Yunzhou Wu, Yuquan Wei, Guangxiao Lin, Deshan Li, Xianlong Ye, Dan Yu, Shenglong Zhu
Publikováno v:
Molecular and Cellular Biochemistry. 420:107-119
The aim of this study is to evaluate the role of fibroblast growth factor 21 (FGF21) in nonalcoholic fatty liver disease (NAFLD) and seek to determine if its therapeutic effect is through induction of autophagy. In this research, Monosodium L-glutama
Autor:
Yikuan Wu, Zhao He, Wanjing Wang, Yue-Lei Chen, Shenglong Zhu, Yuan Zhang, Guangxiao Lin, Ci Song
Publikováno v:
Scientific Reports
Scientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
Scientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
All-trans retinoic acid (ATRA), one of vitamin A derivatives, shows greater growth inhibition of breast cancer cell for ER-positive than ER-negative cells, while triple negative breast cancer cell such as MDA-MB-231 cell is poorly responsive to ATRA
Publikováno v:
Cell biology international. 41(8)
Breast cancer is a leading type of cancer in women and generally classified into three subtypes of ER